Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 14;15(12):377.
doi: 10.3390/jfb15120377.

Application of Advanced Platelet-Rich Fibrin in Oral and Maxillo-Facial Surgery: A Systematic Review

Marek Chmielewski  1 , Andrea Pilloni  2 , Paulina Adamska  3
Affiliations
Review

Application of Advanced Platelet-Rich Fibrin in Oral and Maxillo-Facial Surgery: A Systematic Review

Marek Chmielewski et al. J Funct Biomater. .

Abstract

Background: Advanced platelet-rich fibrin (A-PRF) is produced by centrifuging the patient's blood in vacuum tubes for 14 min at 1500 rpm. The most important component of A-PRF is the platelets, which release growth factors from their ⍺-granules during the clotting process. This process is believed to be the main source of growth factors. The aim of this paper was to systematically review the literature and to summarize the role of A-PRF in oral and maxillo-facial surgery. Materials and Methods: A systematic review was carried out, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (PROSPERO: CRD42024584161). Results: Thirty-eight articles published before 11 November 2024 were included in the systematic review. The largest study group consisted of 102 patients, and the smallest study group consisted of 10 patients. A-PRF was most often analyzed compared to leukocyte-PRF (L-PRF) or blood cloth. A-PRF was correlated with lower postoperative pain. Also, A-PRF was highlighted to have a positive effect on grafting material integration. A-PRF protected areas after free gingival graft very well, promoted more efficient epithelialization of donor sites and enhanced wound healing. Conclusions: Due to its biological properties, A-PRF could be considered a reliable addition to the surgical protocols, both alone and as an additive to bio-materials, with the advantages of healing improvement, pain relief, soft tissue management and bone preservation, as well as graft integration. However, to determine the long-term clinical implications and recommendations for clinical practice, more well-designed randomized clinical trials are needed in each application, especially those with larger patient cohorts, as well as additional blinding of personnel and long follow-up periods.

Keywords: A-PRF; advanced platelet-rich fibrin; autografts; dentistry; growth factors; wound healing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
A-PRF clot in glass-coated plastic tubes.
Figure 2
Figure 2
PRISMA workflow.
Figure 3
Figure 3
The risk of bias assessment using RoS 2 [2,19,20,21,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60].
See this image and copyright information in PMC

References

    1. Dohan D.M., Choukroun J., Diss A., Dohan S.L., Dohan A.J.J., Mouhyi J., Gogly B. Platelet-rich fibrin (PRF): A secondgeneration platelet concentrate. Part I: Technological concepts and evolution. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006;10:37–44. doi: 10.1016/j.tripleo.2005.07.008. - DOI - PubMed
    1. Brancaccio Y., Antonelli A., Barone S., Bennardo F., Fortunato L., Giudice A. Evaluation of local hemostatic efficacy after dental extractions in patients taking antiplatelet drugs: A randomized clinical trial. Clin. Oral Investig. 2021;25:115–1167. doi: 10.1007/s00784-020-03420-3. - DOI - PubMed
    1. Choukroun J., Diss A., Simonpieri A., Girard M.O., Schoeffler C., Dohan S.L., Dohan A.J., Mouhyi J., Dohan D.M. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006;101:e56–e60. doi: 10.1016/j.tripleo.2005.07.011. - DOI - PubMed
    1. Choukroun J., Diss A., Simonpieri A., Girard M.O., Schoeffler C., Dohan S.L., Dohan A.J., Mouhyi J., Dohan D.M. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part V: Histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006;101:299–303. doi: 10.1016/j.tripleo.2005.07.012. - DOI - PubMed
    1. Ghanaati S., Booms P., Orlowska A., Kubesch A., Lorenz J., Rutkowski J., Landes C., Sader R., Kirkpatrick C., Choukroun J. Advanced platelet-rich fibrin: A new concept for cell-based tissue engineering by means of inflammatory cells. J. Oral Implantol. 2014;40:679–689. doi: 10.1563/aaid-joi-D-14-00138. - DOI - PubMed

LinkOut - more resources